UNC is the only medical institution in the world to use high frequency sound waves to inactivate brain tissue that causes epilepsy.

UNC School of Medicine researchers will lead a $3.4 million clinical trial to examine how a non-medication treatment, like a one-of-a-kind wearable device, can calm the body after a traumatic event.

A new study in the lab of Jason Stein, PhD, modeled brain development in a dish to identify cells and genes that influence infant brain growth, a trait associated with autism.

Laura Klinger, PhD, of psychiatry, and Jason Stein, PhD, in genetics, together with Joseph Piven, MD, in psychiatry, received two $4 million grants to study the root causes and improve therapies to help autistic people live happier and healthier lives.

A new study is uncovering ways to assess early suicidal thoughts and behaviors in children as young as 5 –years old.

In the largest study of its kind, psychiatrists and obstetrician-gynecologists at the UNC School of Medicine reveal a quick and accessible psychosocial treatment that drastically reduces suicidal thoughts among pregnant and postpartum women.

A new update, led by researchers at the UNC School of Medicine and the Gillings School of Global Public Health, describes major findings from the past half decade in the realm of psychiatric genomics and next steps for researchers.

Joseph Piven, MD, the Thomas E. Castelloe Distinguished Professor of Psychiatry and Pediatrics and director of the Carolina Institute for Developmental Disabilities was given the award for his fundamental contributions to research on autism spectrum disorders.

Lauren Schiff, MD, a gynecologic surgeon at the UNC School of Medicine, and Ashley Hester, PhD, a psychologist at the UNC TEACCH Autism Program, outline simple ways physicians can improve quality of care for autistic patients – and how these methods can help everyone who comes into the office.

With a designation from the FDA, a device created and patented by Flavio Frohlich, PhD, professor of psychiatry at the UNC School of Medicine and member of the UNC Neuroscience Center, is one step closer to being available for patients.

Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.

Building off previous groundbreaking research, a new study identifies specific genetic variants that have significant impacts on brain development and are shared across eight different psychiatric disorders. Targeting these variants could pave the way for treatments that address multiple conditions at once.

Tag: Psychiatry

Former Marine Undergoes First-of-its-Kind Procedure to Reduce Life-Altering Seizures

UNC Partners with US Department of Defense to Test Wearable Device Designed to Reduce Post-Traumatic Stress

UNC Researchers Build Stem Cell Models to Mimic Early Brain Development

UNC School of Medicine Secures Two Major NIH Grants for Autism Research

UNC Research Uncovers Ways to Address Early Suicidal Thoughts in Children

UNC Physicians Develop Fast Treatment to Ease Depression in Pregnant and Postpartum Women

A Five Year Update About Psychiatric Genomic Research at UNC

Piven Earns Prestigious Lifetime Achievement Award from the International Society for Autism Research

Autistic Patients Need Better Care, Accommodations in the Medical Office

FDA Grants Breakthrough Device Designation for Non-Invasive Brain Stimulation Device to Treat Major Depressive Disorder

Semaglutide Shows Promise in Reducing Cravings for Alcohol, Heavy Drinking

Eight Psychiatric Disorders Share the Same Genetic Causes, Study Says